Publication
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
Liraglutide protects memory, insulin receptors, and synapses
Andre F Batista, Leticia Forny-Germano, Julia R Clarke, Natalia M Lyra e Silva, Jordano Brito-Moreira, Susan E Boehnke, Andrew Winterborn, Brian C Coe, Ann Lablans, Juliana F Vital, Suelen A Marques, Ana MB Martinez, Matthias Gralle, Christian Holscher, William L Klein, Jean-Christophe Houzel, Sergio T Ferreira, Douglas P Munoz, Fernanda G De Felice
The Journal of Pathology, April 2018, Wiley
DOI: 10.1002/path.5056